103 related articles for article (PubMed ID: 15855244)
1. Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy.
Page RL; Klem PM; Rogers C
Ann Pharmacother; 2005 Jun; 39(6):1109-13. PubMed ID: 15855244
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus and lopinavir/ritonavir interaction in liver transplantation.
Schonder KS; Shullo MA; Okusanya O
Ann Pharmacother; 2003 Dec; 37(12):1793-6. PubMed ID: 14632538
[TBL] [Abstract][Full Text] [Related]
3. Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.
Olyaei AJ; deMattos AM; Norman DJ; Bennett WM
Pharmacotherapy; 1998; 18(6):1356-9. PubMed ID: 9855339
[TBL] [Abstract][Full Text] [Related]
4. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine, tacrolimus, and diltiazem might be a hazardous combination in a transplant patient.
Patni H; Gitman M; Hazzan A; Jhaveri KD
Ren Fail; 2012; 34(2):251-3. PubMed ID: 22263871
[TBL] [Abstract][Full Text] [Related]
6. Significant sirolimus and dronedarone interaction in a kidney transplant recipient.
Tichy EM; Medwid AJ; Mills EA; Formica RN; Kulkarni S
Ann Pharmacother; 2010; 44(7-8):1338-41. PubMed ID: 20484171
[TBL] [Abstract][Full Text] [Related]
7. Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study.
Shihab FS; Waid TH; Conti DJ; Yang H; Holman MJ; Mulloy LC; Henning AK; Holman J; First MR;
Transplantation; 2008 May; 85(9):1261-9. PubMed ID: 18475181
[TBL] [Abstract][Full Text] [Related]
8. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
10. Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus.
Chen JS; Li LS; Cheng DR; Ji SM; Sun QQ; Cheng Z; Wen JQ; Sha GZ; Liu ZH
Transplant Proc; 2009 Jun; 41(5):1557-61. PubMed ID: 19545678
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.
Chan L; Greenstein S; Hardy MA; Hartmann E; Bunnapradist S; Cibrik D; Shaw LM; Munir L; Ulbricht B; Cooper M;
Transplantation; 2008 Mar; 85(6):821-6. PubMed ID: 18360262
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
[TBL] [Abstract][Full Text] [Related]
14. Varenicline-associated acute renal failure.
Bird ML; Vesta KS
Ann Pharmacother; 2008 Dec; 42(12):1908-11. PubMed ID: 18984856
[TBL] [Abstract][Full Text] [Related]
15. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
16. Increased topical tacrolimus absorption in generalized leukemic erythroderma.
Teshima D; Ikesue H; Itoh Y; Urabe K; Furue M; Oishi R
Ann Pharmacother; 2003 Oct; 37(10):1444-7. PubMed ID: 14519034
[TBL] [Abstract][Full Text] [Related]
17. Preapheresis immunosuppressive induction: necessary or harmful?
Wennberg L; Genberg H; Tydén G
Transplantation; 2007 Dec; 84(12 Suppl):S37-9. PubMed ID: 18162987
[TBL] [Abstract][Full Text] [Related]
18. Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study.
Pascual J; Marcén R; Orea OE; Navarro M; Alarcón MC; Ocaña J; Villafruela JJ; Burgos FJ; Ortuño J
Transplant Proc; 2005 Nov; 37(9):3752-3. PubMed ID: 16386527
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus (Pan Graf) as de novo therapy in renal transplant recipients in India.
Guleria S; Kamboj M; Singh P; Sharma M; Pandey S; Chatterjee A; Dinda AK; Mahajan S; Gupta S; Bhowmik D; Agarwal SK; Tiwari SC; Dash SC
Transplant Proc; 2006 Sep; 38(7):2029-31. PubMed ID: 16979989
[TBL] [Abstract][Full Text] [Related]
20. Drug interaction between tacrolimus and carbamazepine in a Japanese heart transplant recipient: a case report.
Wada K; Takada M; Sakai M; Ochi H; Kotake T; Okada H; Morishita H; Oda N; Mano A; Kato TS; Komamura K; Nakatani T
J Heart Lung Transplant; 2009 Apr; 28(4):409-11. PubMed ID: 19332272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
